Wed, Jul 23, 2014, 7:45 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Anacor Pharmaceuticals, Inc. (ANAC) Message Board

  • sleestak_12 sleestak_12 Dec 12, 2012 3:35 PM Flag

    SUED

    Just popped up on etrade

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Dec 12, 2012 article...old news not worth reading.

      Sentiment: Strong Buy

    • Looks like Medicus is a day late to the dance, I would think this would be a great time to load up more of ANAC

    • no impact on lead P2/3 programs

    • Guns-to-Work Laws Turn Pistol-Wary Business on NRAQ

      Vanatta: Operation Twist Should Get More AirtimeQ
      0:59
      Truffle Hunters Use Pigs, Dogs to Dig Up ProfitsQ

      Millionaires Scramble for Shelter as Bush Tax Cuts Near EndQ

      24 Hours to Drill: Antarctic Quest for Life Miles Under IceQ

      Blankfein: Next CEO Already Works for GoldmanQ

      Guns-to-Work Laws Turn Pistol-Wary Business on NRAQ

      Vanatta: Operation Twist Should Get More AirtimeQ
      0:59
      Truffle Hunters Use Pigs, Dogs to Dig Up ProfitsQ

      Millionaires Scramble for Shelter as Bush Tax Cuts Near EndQ

      24 Hours to Drill: Antarctic Quest for Life Miles Under IceQ

      Blankfein: Next CEO Already Works for GoldmanQ
      WATCH LIVE
      Bernanke Press Conference: Would Chairman Stay On? Too Busy to Think About His Own Future

      Valeant’s Medicis Sues Anacor Over Research Collaboration
      By Phil Milford - Dec 12, 2012 2:20 PM ET
      Facebook Share
      LinkedIn
      Google +1
      0 COMMENTS
      Print
      QUEUE
      Q
      Valeant Pharmaceuticals International Inc. (VRX)’s Medicis unit, which makes drugs to treat skin conditions, sued Anacor Pharmaceuticals Inc. (ANAC) alleging violation of a collaborative research agreement.
      Medicis wants a judge to force Anacor to comply with its contract and to issue “a permanent injunction against an improper arbitration,” according to papers filed in Delaware Chancery Court in Wilmington yesterday.
      The complaint was filed under seal, with additional public information in other documents. Terms of the agreement weren’t specified. Palo Alto, California-based Anacor said in an Oct. 5 statement that it had a research-and-development agreement with Medicis to help discover small-molecule compounds to treat acne.
      An Anacor spokeswoman, DeDe Sheel, didn’t immediately return a voice-mail message seeking comment on the dispute.
      Valeant is based in Montreal, and Medicis is based in Scottsdale, Arizona.

 
ANAC
16.95+0.50(+3.04%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.